88IV - PR Newswire Asia's news


Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026 New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active Crohn's ... 2026-10-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™ Award recognizes innovation, design excellence, and impact in Engineering Design ... 2026-10-10T Biotechnology Computer/Electronics Health Care/Hospital Infectious Disease Control
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026 SHANGHAI and HONG KONG , Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at Moderna, ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease SYCUME ® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid Eye Disease(TED) SAN ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Telix to Host Capital Markets Day in Melbourne on November 4, 2026 MELBOURNE, Australia and INDIANAPOLIS , Oct. 9, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announced that it will host a Capital Markets Day in ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation Inaugural competition will connect emerging AI life sciences platforms with validation expertise, investors, and ecosystem partners during JPM Week ... 2026-10-08T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering TAIZHOU, China , Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain ... 2026-10-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SECuRE update: recruitment target of the Cohort Expansion Main Group achieved SYDNEY , Oct. 8, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation ... 2026-10-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology BOSTON , Oct. 8, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc. , (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic ... 2026-10-08T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology